News
For media inquiries or for expert commentary, please contact David Aberle at 612-727-2000.
8 Biopharma Trends to Watch in 2020
Geneticists Inspire Innovation at National Swine Improvement Federation
Twin Cities Business (TCB) 100: The People to Know in 2020
Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta
Company Statement & FAQs on Plasmid Insertion Found in First Gene-Edited Bull
Precision Breeding’s New Horizons
Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor
The Alliance to End Surgical Castration of Swine Announces Precision Breeding Successes
